跳至主要内容
临床试验/NCT03429387
NCT03429387已完成不适用

Early Diagnosis and Treatment of Infections in Patients With Haematologic Malignancies: Examining Novel Diagnostics Including Bacterial and Fungal Multiplex PCR and FDG-PET Imaging

Peter MacCallum Cancer Centre, Australia2 个研究点 分布在 1 个国家目标入组 147 人开始时间: 2018年1月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
147
试验地点
2
主要终点
Change in management following randomized scan

研究概览

简要总结

Patients with acute leukaemia requiring induction or consolidation chemotherapy and those requiring a haematopoietic stem cell transplant are at high risk of fever and infection when they have low white cell counts (neutropenic fever). The causes of neutropenic fever are frequently unknown and patients are treated with broad antibiotics, without a clear target to what is being treated.

This study will prospectively enroll patients who are receiving chemotherapy for acute leukaemia or for a stem cell transplant and compare the diagnostic utility of bacterial and fungal PCR performed directly off blood drawn, to the standard blood culture. Patients who have persistent fever after 72 hours of antibiotics will then be randomized to have either the interventional scan (PET/CT) or the conventional scan (standard CT) to look for a source of infection. Diagnostic yield, change in management and outcomes will be compared between arms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •About to have an allogeneic haematopoietic stem cell transplant, OR
  • •About to have an autologous haematopoietic stem cell transplant, OR
  • •Commencing induction or consolidation chemotherapy with curative intent for acute myeloid or acute lymphoid leukaemia

排除标准

  • •Current actively diagnosed infection prior to transplant or chemotherapy
  • •Allergy to intravenous contrast for CT imaging
  • •eGFR <30

研究组 & 干预措施

FDG-PET/CT arm

Experimental

Participants with persistent febrile neutropenia after 72 hours of onset who are randomized to this arm will have an FDG-PET/CT performed to look for source of fever.

干预措施: FDG-PET/CT (Diagnostic Test)

Conventional CT arm

Active Comparator

Participants with persistent febrile neutropenia after 72 hours of onset who are randomized to this arm will have a conventional CT (HRCT chest and sinuses +/- other regions as per clinician's discretion) performed to look for source of fever.

干预措施: Conventional CT (Diagnostic Test)

结局指标

主要结局

Change in management following randomized scan

时间窗: Within 48 hours of scan result

Defined as: * referral for targeted sampling, referral for surgery * change in antimicrobial therapy * removal of a central line

次要结局

  • Proportion of participants with a cause of neutropenic fever(By hospital discharge, an average of 4 weeks)
  • In hospital mortality(By hospital discharge, an average of 4 weeks)
  • Hospital length of stay(By hospital discharge, an average of 4 weeks)
  • Proportion admitted to intensive care(By hospital discharge, an average of 4 weeks)
  • 6 month mortality(6 months from study entry)
  • Costs of hospital care(By hospital discharge, an average of 4 weeks)

研究者

发起方
Peter MacCallum Cancer Centre, Australia
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验